Optimising CMR Scan Acquisitions for Novel Equipment/Sequences in Clinical Cardiovascular Populations.
NCT ID: NCT06311552
Last Updated: 2024-03-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
30 participants
OBSERVATIONAL
2022-01-31
2023-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF
NCT06316661
Role of Cardiac Computed Tomography in Optimising Response to Cardiac Resynchronisation Therapy
NCT02434159
Improved Prediction of Functional Recovery After Revascularisation Using Combined Assessment of Myocardial Ischaemia and Viability by CMR - Pilot Study
NCT03798652
Cardiac Magnetic Resonance Tomography for Heart Failure With Preserved Ejection Fraction
NCT05322109
Validation of PET-MRI for Cardiovascular Disease
NCT02988531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CMR scan on either a 1.5- or 3-Tesla scanner
Participants will undergo a comprehensive CMR scan on either a 1.5- or 3-Tesla scanner
Participants will undergo a comprehensive CMR scan on either a 1.5- or 3-Tesla scanner
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Participants will undergo a comprehensive CMR scan on either a 1.5- or 3-Tesla scanner
Participants will undergo a comprehensive CMR scan on either a 1.5- or 3-Tesla scanner
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either a clinical diagnosis of HFpEF, be at risk of or pre- HFpEF
Exclusion Criteria
* Unable to read/understand English sufficiently to provide informed consent
* Pregnancy
* Unable to consent due to lack of mental capacity
* Current cancer diagnosis and actively undergoing treatment
* Inability to exercise on the MRI ergometer
* Severe claustrophobia
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leicester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Glenfield Hospital
Leicester, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0856
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.